Ï㽶ÊÓƵ

Skip to main content
Torri D. Metz
( out of 14 reviews )

Torri D. Metz, MD, MS

Languages spoken: English

Clinical Locations

Farmington Health Center

Farmington
801-213-3200
  • Dr. Torri Metz's commitment is to advance the treatment of individuals during pregnancy. She focuses on the care and management of patients with chronic medical conditions during pregnancy. Outside of work, Dr. Metz enjoys time with her family, exploring the vast array of outdoor activities that Utah has to offer, from hiking to skiing.

    She is currently accepting new patients and does both consults and prenatal care including ultrasound at our Farmington Health Center location. To schedule an appointment with Dr. Metz, please call the women's health center at 801-581-8425.

    In Dr. Metz’s clinical practice, she is dedicated to advanced treatment and management strategies for pregnant individuals facing complex health issues. As a clinical researcher, she explores significant topics such as the effects of cannabis use during pregnancy on both mother and newborn, maternal cardiac disease, and reducing maternal morbidity and mortality. Dr. Metz is recognized as a national expert in Maternal-Fetal medicine.

    Dr. Metz completed her undergraduate degree in Chemistry at the Ï㽶ÊÓƵ of Colorado Boulder before earning her MD at the Ï㽶ÊÓƵ of Colorado School of Medicine. She then specialized in Obstetrics & Gynecology during her residency at the Ï㽶ÊÓƵ of Colorado Denver. Dr. Metz furthered her expertise with a fellowship in Maternal-Fetal Medicine and participated in the NIH-Sponsored Clinical and Translational Science Training Program, both at the Ï㽶ÊÓƵ of Utah School of Medicine, earning an MS in Clinical Investigation.

    She holds board certifications from the American Board of Obstetrics & Gynecology in both Obstetrics & Gynecology and Maternal-Fetal Medicine. Dr. Metz is an Associate Professor of Obstetrics and Gynecology and serves as the Vice Chair for Research in Obstetrics and Gynecology and Division Chief for Maternal-Fetal Medicine. Dr. Metz's academic roles include leadership positions within the Obstetrics and Gynecology departments and nationally with organizations such as the Society for Maternal-Fetal Medicine, emphasizing her commitment to advancing medical education, clinical care, and research in her field.

    Board Certification

    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Patient Rating

    4.9 /5
    ( out of 14 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 19, 2024
    FARMINGTON HEALTH CENTER

    She's great! I enjoy my visits and know I'm in good hands.

    June 07, 2024
    GREENWOOD HEALTH CENTER

    Muy buena atención te explica todo muy bien

    January 26, 2024
    FARMINGTON HEALTH CENTER

    Dr. Metz is great. She is extremely knowledgeable and took the time to answer my questions. She is thoughtful and relatable. During my visit, she was able to squeeze in extra testing I needed but wasn't originally scheduled for. Her practice is very responsive and helpful. I had to change care due to insurance issues but wish I could have stayed with Dr. Metz!

    November 30, 2023
    GREENWOOD HEALTH CENTER

    I love Dr. Metz! She spends adequate time with me during each visit and I appreciate that she is straightforward.

    April 20, 2023
    FARMINGTON HEALTH CENTER

    Dr. Metz is amazing, I feel very lucky to be on her care team. She has been attentive and helped me with any questions I have had during my pregnancy so far and I feel ready and confident to give birth.

    March 16, 2023
    FARMINGTON HEALTH CENTER

    Dr. Metz is very kind and I always feel like she listens to any questions I have. She is very knowledgeable and always makes me feel like Ive received the best care possible.

    February 01, 2023
    FARMINGTON HEALTH CENTER

    Dr. Metz is compassionate and very knowledgeable.

    November 27, 2022
    Farmington Health Center

    It was nice to be listened to and have things explained. I can tell Dr. Metz is highly effective at what she does and believes in informing patients of the reasoning.

  • Dr. Torri Metz's commitment is to advance the treatment of individuals during pregnancy. She focuses on the care and management of patients with chronic medical conditions during pregnancy. Outside of work, Dr. Metz enjoys time with her family, exploring the vast array of outdoor activities that Utah has to offer, from hiking to skiing.

    She is currently accepting new patients and does both consults and prenatal care including ultrasound at our Farmington Health Center location. To schedule an appointment with Dr. Metz, please call the women's health center at 801-581-8425.

    In Dr. Metz’s clinical practice, she is dedicated to advanced treatment and management strategies for pregnant individuals facing complex health issues. As a clinical researcher, she explores significant topics such as the effects of cannabis use during pregnancy on both mother and newborn, maternal cardiac disease, and reducing maternal morbidity and mortality. Dr. Metz is recognized as a national expert in Maternal-Fetal medicine.

    Dr. Metz completed her undergraduate degree in Chemistry at the Ï㽶ÊÓƵ of Colorado Boulder before earning her MD at the Ï㽶ÊÓƵ of Colorado School of Medicine. She then specialized in Obstetrics & Gynecology during her residency at the Ï㽶ÊÓƵ of Colorado Denver. Dr. Metz furthered her expertise with a fellowship in Maternal-Fetal Medicine and participated in the NIH-Sponsored Clinical and Translational Science Training Program, both at the Ï㽶ÊÓƵ of Utah School of Medicine, earning an MS in Clinical Investigation.

    She holds board certifications from the American Board of Obstetrics & Gynecology in both Obstetrics & Gynecology and Maternal-Fetal Medicine. Dr. Metz is an Associate Professor of Obstetrics and Gynecology and serves as the Vice Chair for Research in Obstetrics and Gynecology and Division Chief for Maternal-Fetal Medicine. Dr. Metz's academic roles include leadership positions within the Obstetrics and Gynecology departments and nationally with organizations such as the Society for Maternal-Fetal Medicine, emphasizing her commitment to advancing medical education, clinical care, and research in her field.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Primary
    Academic Divisions Maternal Fetal Medicine
    Board Certification
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Education history

    Fellowship Maternal-Fetal Medicine - Ï㽶ÊÓƵ of Utah School of Medicine Fellow
    Graduate Training NIH-Sponsored Clinical and Translational Science Training Program - Ï㽶ÊÓƵ of Utah School of Medicine M.S.C.I
    Residency Obstetrics & Gynecology - Ï㽶ÊÓƵ of Colorado Denver Resident
    Professional Medical Medicine - Ï㽶ÊÓƵ of Colorado School of Medicine M.D.
    Undergraduate Chemistry - Ï㽶ÊÓƵ of Colorado Boulder B.A.

    Selected Publications

    Journal Article

    1. McMillin GA, Morad AW, Boyd JM, Johnson-Davis KL, Metz TD, Smid MC, Krasowski MD (2024). Biological Testing and Interpretation of Laboratory Results Associated with Detecting Newborns with Substance Exposure. Clin Chem, 70(7), 934-947. ()
    2. Grasch JL, de Voest JA, Saade GR, Hughes BL, Reddy UM, Costantine MM, Chien EK, Tita ATN, Thorp JM Jr, Metz TD, Wapner RJ, Sabharwal V, Simhan HN, Swamy GK, Heyborne KD, Sibai BM, Grobman WA, El-Sayed YY, Casey BM, Parry S, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2024). Breastfeeding Initiation, Duration, and Associated Factors Among People With Hepatitis C Virus Infection. Obstet Gynecol, 143(3), 449-455. ()
    3. Bruno AM, Sandoval GJ, Hughes BL, Grobman WA, Saade GR, Manuck TA, Longo M, Metz TD, Simhan HN, Rouse DJ, Mendez-Figueroa H, Gyamfi-Bannerman C, Bailit JL, Costantine MM, Sehdev HM, Tita ATN, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Bethesda MD (2024). Postpartum pharmacologic thromboprophylaxis and complications in a US cohort. Am J Obstet Gynecol. ()
    4. Bruno AM, Horns JJ, Metz TD (2023). Coronavirus Disease 2019 (COVID-19) and Venous Thromboembolism During Pregnancy and Postpartum. Obstet Gynecol, 143(1), 139-142. ()
    5. Bailey EJ, Tita ATN, Leach J, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz TD, Casey BM, Esplin S, Longo S, Hoffman M, Saade GR, Foroutan J, Tuuli MG, Owens MY, Simhan HN, Frey HA, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su EJ, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Oparil S, Kuo HC, Szychowski JM, Hoppe K (2023). Perinatal Outcomes Associated With Management of Stage 1 Hypertension. Obstet Gynecol, 142(6), 1395-1404. ()
    6. Wyszynski DF, Papageorghiou AT, Renz C, Metz TD, Hernndez-Daz S (2023). The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations. Drug Saf. ()
    7. Canfield DR, Allshouse AA, Smith J, Metz TD, Grobman WA, Silver RM (2023). Labour agentry and subsequent adverse mental health outcomes: A follow-up study of the ARRIVE Trial. BJOG. ()
    8. Sandoval GJ, Grobman WA, Evans SR, Rice MM, Clifton RG, Chauhan SP, Costantine MM, Gibson KS, Longo M, Metz TD, Miller ES, Parry S, Reddy UM, Rouse DJ, Simhan HN, Thorp JM Jr, Tita ATN, Saade GR, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units MFMU Network (2023). Desirability of outcome ranking for obstetrical trials: illustration and application to the ARRIVE trial. Am J Obstet Gynecol. ()
    9. Lo JO, Hedges JC, Metz TD (2023). Cannabis Use and Perinatal Health Research. JAMA, 330(10), 913-914. ()
    10. Powers S, Han X, Martinez J, Dufford AJ, Metz TD, Yeh T, Kim P (2023). Cannabis use during pregnancy and hemodynamic responses to infant cues in pregnancy: an exploratory study. Front Psychiatry, 14, 1180947. ()
    11. Goulding AN, Antoniewicz L, Leach JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Edwards RK, Gibson K, Haas DM, Plante L, Metz TD, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Harper LM, Ambalavanan N, Oparil S, Szychowski JM, Tita AT, Chronic Hypertension and Pregnancy Trial Consortium (2023). Breastfeeding initiation and duration among people with mild chronic hypertension: a secondary analysis of the Chronic Hypertension and Pregnancy trial. Am J Obstet Gynecol MFM, 5(9), 101086. ()
    12. Metz TD (2023). Vaccines for pregnant people: are we missing the forest for the trees? Lancet Digit Health, 5(9), e546-e547. ()
    13. Prasad M, Saade GR, Clifton RG, Sandoval GJ, Hughes BL, Reddy UM, Bartholomew A, Salazar A, Chien EK, Tita ATN, Thorp JM Jr, Metz TD, Wapner RJ, Sabharwal V, Simhan HN, Swamy GK, Heyborne KD, Sibai BM, Grobman WA, El-Sayed YY, Casey BM, Parry S, Rathore M, Diaz-Velasco R, Puga AM, Wiznia A, Kovacs A, Garry DJ, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2023). Risk Factors for Perinatal Transmission of Hepatitis C Virus. Obstet Gynecol, 142(3), 449-456. ()
    14. Jepson BM, Metz TD, Miller TA, Son SL, Ou Z, Presson AP, Nance A, Pinto NM (2023). Pregnancy loss in major fetal congenital heart disease: incidence, risk factors and timing. Ultrasound Obstet Gynecol, 62(1), 75-87. ()
    15. Caritis SN, Costantine MM, Clark S, Stika CS, Kiley JW, Metz TD, Chauhan SP, Venkataramanan R, Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric-Fetal Pharmacology Research Centers Network (2023). Relationship between plasma concentration of 17-hydroxyprogesterone caproate and gestational age at preterm delivery. Am J Obstet Gynecol MFM, 5(7), 100980. ()
    16. Horwitz LI, Thaweethai T, Brosnahan SB, Cicek MS, Fitzgerald ML, Goldman JD, Hess R, Hodder SL, Jacoby VL, Jordan MR, Krishnan JA, Laiyemo AO, Metz TD, Nichols L, Patzer RE, Sekar A, Singer NG, Stiles LE, Taylor BS, Ahmed S, Algren HA, Anglin K, Aponte-Soto L, Ashktorab H, Bassett IV, Bedi B, Bhadelia N, Bime C, Bind MC, Black LJ, Blomkalns AL, Brim H, Castro M, Chan J, Charney AW, Chen BK, Chen LQ, Chen P, Chestek D, Chibnik LB, Chow DC, Chu HY, Clifton RG, Collins S, Costantine MM, Cribbs SK, Deeks SG, Dickinson JD, Donohue SE, Durstenfeld MS, Emery IF, Erlandson KM, Facelli JC, Farah-Abraham R, Finn AV, Fischer MS, Flaherman VJ, Fleurimont J, Fonseca V, Gallagher EJ, Gander JC, Gennaro ML, Gibson KS, Go M, Goodman SN, Granger JP, Greenway FL, Hafner JW, Han JE, Harkins MS, Hauser KSP, Heath JR, Hernandez CR, Ho O, Hoffman MK, Hoover SE, Horowitz CR, Hsu H, Hsue PY, Hughes BL, Jagannathan P, James JA, John J, Jolley S, Judd SE, Juskowich JJ, Kanjilal DG, Karlson EW, Katz SD, Kelly JD, Kelly SW, Kim AY, Kirwan JP, Knox KS, Kumar A, Lamendola-Essel MF, Lanca M, Lee-Lannotti JK, Lefebvre RC, Levy BD, Lin JY, Logarbo BP Jr, Logue JK, Longo MT, Luciano CA, Lutrick K, Malakooti SK, Mallett G, Maranga G, Marathe JG, Marconi VC, Marshall GD, Martin CF, Martin JN, May HT, McComsey GA, McDonald D, Mendez-Figueroa H, Miele L, Mittleman MA, Mohandas S, Mouchati C, Mullington JM, Nadkarni GN, Nahin ER, Neuman RB, Newman LT, Nguyen A, Nikolich JZ, Ofotokun I, Ogbogu PU, Palatnik A, Palomares KTS, Parimon T, Parry S, Parthasarathy S, Patterson TF, Pearman A, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Porterfield JZ, Quigley JG, Quinn DK, Raissy H, Rebello CJ, Reddy UM, Reece R, Reeder HT, Rischard FP, Rosas JM, Rosen CJ, Rouphael NG, Rouse DJ, Ruff AM, Saint Jean C, Sandoval GJ, Santana JL, Schlater SM, Sciurba FC, Selvaggi C, Seshadri S, Sesso HD, Shah DP, Shemesh E, Sherif ZA, Shinnick DJ, Simhan HN, Singh U, Sowles A, Subbian V, Sun J, Suthar MS, Teunis LJ, Thorp JM Jr, Ticotsky A, Tita ATN, Tragus R, Tuttle KR, Urdaneta AE, Utz PJ, VanWagoner TM, Vasey A, Vernon SD, Vidal C, Walker T, Ward HD, Warren DE, Weeks RM, Weiner SJ, Weyer JC, Wheeler JL, Whiteheart SW, Wiley Z, Williams NJ, Wisnivesky JP, Wood JC, Yee LM, Young NM, Zisis SN, Foulkes AS (2023). Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLoS One, 18(6), e0286297. ()
    17. Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, Walker TA, Selvaggi CA, Shinnick DJ, Schulte CCM, Atchley-Challenner R, Alba GA, Alicic R, Altman N, Anglin K, Argueta U, Ashktorab H, Baslet G, Bassett IV, Bateman L, Bedi B, Bhattacharyya S, Bind MA, Blomkalns AL, Bonilla H, Bush PA, Castro M, Chan J, Charney AW, Chen P, Chibnik LB, Chu HY, Clifton RG, Costantine MM, Cribbs SK, Davila Nieves SI, Deeks SG, Duven A, Emery IF, Erdmann N, Erlandson KM, Ernst KC, Farah-Abraham R, Farner CE, Feuerriegel EM, Fleurimont J, Fonseca V, Franko N, Gainer V, Gander JC, Gardner EM, Geng LN, Gibson KS, Go M, Goldman JD, Grebe H, Greenway FL, Habli M, Hafner J, Han JE, Hanson KA, Heath J, Hernandez C, Hess R, Hodder SL, Hoffman MK, Hoover SE, Huang B, Hughes BL, Jagannathan P, John J, Jordan MR, Katz SD, Kaufman ES, Kelly JD, Kelly SW, Kemp MM, Kirwan JP, Klein JD, Knox KS, Krishnan JA, Kumar A, Laiyemo AO, Lambert AA, Lanca M, Lee-Iannotti JK, Logarbo BP, Longo MT, Luciano CA, Lutrick K, Maley JH, Marathe JG, Marconi V, Marshall GD, Martin CF, Matusov Y, Mehari A, Mendez-Figueroa H, Mermelstein R, Metz TD, Morse R, Mosier J, Mouchati C, Mullington J, Murphy SN, Neuman RB, Nikolich JZ, Ofotokun I, Ojemakinde E, Palatnik A, Palomares K, Parimon T, Parry S, Patterson JE, Patterson TF, Patzer RE, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Quigley JG, Reddy U, Reece R, Reeder H, Reeves WB, Reiman EM, Rischard F, Rosand J, Rouse DJ, Ruff A, Saade G, Sandoval GJ, Schlater SM, Shepherd F, Sherif ZA, Simhan H, Singer NG, Skupski DW, Sowles A, Sparks JA, Sukhera FI, Taylor BS, Teunis L, Thomas RJ, Thorp JM, Thuluvath P, Ticotsky A, Tita AT, Tuttle KR, Urdaneta AE, Valdivieso D, VanWagoner TM, Vasey A, Verduzco-Gutierrez M, Wallace ZS, Ward HD, Warren DE, Weiner SJ, Welch S, Whiteheart SW, Wiley Z, Wisnivesky JP, Yee LM, Zisis S, Horwitz LI, Foulkes AS, RECOVER Consortium (2023). Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA, 329(22), 1934-1946. ()
    18. Merriam AA, Metz TD, Allshouse AA, Silver RM, Haas DM, Grobman WA, Simhan HN, Wapner RJ, Wing D, Mercer BM, Parry S, Reddy UM, nuMoM2b Investigators (2023). Maternal Morbidity Risk Factors in Nulliparas. Am J Perinatol. ()
    19. Smith C, Fought AJ, Sung JF, McKinney JR, Metz TD, Fetters KB, Lazarus S, Capraro S, Barr E, Glenny C, Buehler J, Weinberg A, CHIP Perinatal Medical Team (2023). Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis. PLoS One, 18(6), e0276473. ()
    20. Grobman WA, Sandoval GJ, Metz TD, Manuck TA, Clifton RG, Hughes BL, Saade GR, Longo M, Sowles A, Clark K, Simhan HN, Rouse DJ, Mendez-Figueroa H, Gyamfi-Bannerman C, Bailit JL, Costantine MM, Sehdev HM, Tita ATN, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2023). The Temporal Relationship Between the Coronavirus Disease 2019 (COVID-19) Pandemic and Preterm Birth. Obstet Gynecol, 141(6), 1171-1180. ()
    21. Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, Longo M, Salazar A, Dalton W, Tita ATN, Gyamfi-Bannerman C, Chauhan SP, Metz TD, Rood K, Rouse DJ, Bailit JL, Grobman WA, Simhan HN, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development MaternalFetal Medicine Units Network (2023). Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery. N Engl J Med, 388(15), 1365-1375. ()
    22. Bruno AM, Allshouse AA, Metz TD, Theilen LH (2023). Hypertensive disorders of pregnancy pre- and postaspirin guideline publication in individuals with pregestational diabetes mellitus. Am J Obstet Gynecol MFM, 5(4), 100877. ()
    23. American College of Obstetricians and Gynecologists Committee on Clinical Consensus-Obstetrics, Gantt A, Society for Maternal-Fetal Medicine, Metz TD, Kuller JA, Louis JM, Society for Maternal-Fetal Medicine, Cahill AG, Turrentine MA, American College of Obstetricians and Gynecologists (2022). Obstetric Care Consensus #11, Pregnancy at age 35 years or older. Am J Obstet Gynecol, 228(3), B25-B40. ()
    24. Hughes BL, Sandoval GJ, Metz TD, Clifton RG, Grobman WA, Saade GR, Manuck TA, Longo M, Sowles A, Clark K, Simhan HN, Rouse DJ, Mendez-Figueroa H, Gyamfi-Bannerman C, Bailit J, Costantine MM, Sehdev HM, Tita ATN, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network (2022). First- or second-trimester SARS-CoV-2 infection and subsequent pregnancy outcomes. Am J Obstet Gynecol, 228(2), 226.e1-226.e9. ()
    25. Harper LM, Leach JM, Robbins L, Blanchard C, Metz TD, Mazzoni S, Nash E, Szychowski J (2022). All-Cause Mortality in Reproductive-Aged Females by State: An Analysis of the Effects of Abortion Legislation. Obstet Gynecol, 141(2), 236-242. ()
    26. Bruno AM, Horns JJ, Allshouse AA, Metz TD, Debbink ML, Smid MC (2023). Association Between Periviable Delivery and New Onset of or Exacerbation of Existing Mental Health Disorders. Obstet Gynecol, 141(2), 395-402. ()
    27. Bruno AM, Horns JJ, Allshouse AA, Das R, Paudel N, Silver RM, Metz TD (2022). Physician cesarean delivery rates and severe perinatal morbidity among low-risk nulliparas. J Perinatol, 43(1), 34-38. ()
    28. Metz TD, Clifton RG, Hughes BL, Sandoval GJ, Grobman WA, Saade GR, Manuck TA, Longo M, Sowles A, Clark K, Simhan HN, Rouse DJ, Mendez-Figueroa H, Gyamfi-Bannerman C, Bailit JL, Costantine MM, Sehdev HM, Tita ATN, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2022). Association Between Giving Birth During the Early Coronavirus Disease 2019 (COVID-19) Pandemic and Serious Maternal Morbidity. Obstet Gynecol, 141(1), 109-118. ()
    29. Smith ER, Oakley E, Grandner GW, Ferguson K, Farooq F, Afshar Y, Ahlberg M, Ahmadzia H, Akelo V, Aldrovandi G, Tippett Barr BA, Bevilacqua E, Brandt JS, Broutet N, Fernndez Buhigas I, Carrillo J, Clifton R, Conry J, Cosmi E, Crispi F, Crovetto F, Delgado-Lpez C, Divakar H, Driscoll AJ, Favre G, Flaherman VJ, Gale C, Gil MM, Gottlieb SL, Gratacs E, Hernandez O, Jones S, Kalafat E, Khagayi S, Knight M, Kotloff K, Lanzone A, Le Doare K, Lees C, Litman E, Lokken EM, Laurita Longo V, Madhi SA, Magee LA, Martinez-Portilla RJ, McClure EM, Metz TD, Miller ES, Money D, Moungmaithong S, Mullins E, Nachega JB, Nunes MC, Onyango D, Panchaud A, Poon LC, Raiten D, Regan L, Rukundo G, Sahota D, Sakowicz A, Sanin-Blair J, Sderling J, Stephansson O, Temmerman M, Thorson A, Tolosa JE, Townson J, Valencia-Prado M, Visentin S, von Dadelszen P, Adams Waldorf K, Whitehead C, Yassa M, Tielsch JM, Perinatal COVID PMA Study Collaborators, Perinatal COVID PMA Study Collaborators (2022). Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health, 8(1). ()
    30. Bruno AM, Allshouse AA, Metz TD (2022). Trends in Attempted and Successful Trial of Labor After Cesarean Delivery in the United States From 2010 to 2020. Obstet Gynecol, 141(1), 173-175. ()
    31. Bruno AM, Benson AE, Metz TD, Blue NR (2022). Adjunct Therapy at Time of Examination-Indicated Cervical Cerclage in Singleton Pregnancies: A Systematic Review and Meta-analysis. Am J Perinatol, 39(16), 1719-1725. ()
    32. Bruno AM, Allshouse AA, Campbell HM, Branch DW, Lim MY, Silver RM, Metz TD (2022). Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol, 140(4), 575-583. ()
    33. Bruno AM, Metz TD, Grobman WA, Silver RM (2022). Defining a Cesarean Delivery Rate for Optimizing Maternal and Neonatal Outcomes. Obstet Gynecol, 140(3), 399-407. ()
    34. Smid MC, Allshouse AA, McMillin GA, Nunez K, Cavin T, Worden J, Buchi K, Muniyappa B, Varner MW, Cochran G, Metz TD (2022). Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah. Obstet Gynecol, 140(2), 153-162. ()
    35. Smith ER, Oakley E, He S, Zavala R, Ferguson K, Miller L, Grandner GW, Abejirinde IO, Afshar Y, Ahmadzia H, Aldrovandi G, Akelo V, Tippett Barr BA, Bevilacqua E, Brandt JS, Broutet N, Fernndez Buhigas I, Carrillo J, Clifton R, Conry J, Cosmi E, Delgado-Lpez C, Divakar H, Driscoll AJ, Favre G, Flaherman V, Gale C, Gil MM, Godwin C, Gottlieb S, Hernandez Bellolio O, Kara E, Khagayi S, Kim CR, Knight M, Kotloff K, Lanzone A, Le Doare K, Lees C, Litman E, Lokken EM, Laurita Longo V, Magee LA, Martinez-Portilla RJ, McClure E, Metz TD, Money D, Mullins E, Nachega JB, Panchaud A, Playle R, Poon LC, Raiten D, Regan L, Rukundo G, Sanin-Blair J, Temmerman M, Thorson A, Thwin S, Tolosa JE, Townson J, Valencia-Prado M, Visentin S, von Dadelszen P, Adams Waldorf K, Whitehead C, Yang H, Thorlund K, Tielsch JM (2022). Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods. PLoS One, 17(6), e0270150. ()
    36. Metz TD, Wylie BJ (2022). Foreword: Conventional Cigarettes, E-cigarettes, and Marijuana Use in Pregnancy. Clin Obstet Gynecol, 65(2), 302-304. ()
    37. Metz TD (2022). Is It Exposure to the Pandemic or to Maternal SARS-CoV-2 Infection That Is Adversely Affecting Early Childhood Neurodevelopment? JAMA Netw Open, 5(6), e2215793. ()
    38. Smid MC, Metz TD (2022). In Reply. Obstet Gynecol, 139(5), 939-940. ()
    39. Bruno AM, Benson AE, Metz TD, Blue NR (2022). Adjunct Therapy at Time of Exam-Indicated Cervical Cerclage in Singleton Pregnancies: A Systematic Review and Meta-Analysis. Am J Perinatol.
    40. Wang GS, Buttorff C, Wilks A, Schwam D, Metz TD, Tung G, Pacula RL (2022). Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado. Prev Med, 156, 106993. ()
    41. Metz TD, Clifton RG, Hughes BL, Sandoval GJ, Grobman WA, Saade GR, Manuck TA, Longo M, Sowles A, Clark K, Simhan HN, Rouse DJ, Mendez-Figueroa H, Gyamfi-Bannerman C, Bailit JL, Costantine MM, Sehdev HM, Tita ATN, Macones GA, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units MFMU Network (2022). Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications. JAMA, 327(8), 748-759. ()
    42. Metz TD, McMillin GA, Silver RM, Allshouse AA, Heard K, Jensen TL, Wymore EM, Stickrath E, Conageski C, Kinney GL, Binswanger IA (2021). Quantification of prenatal marijuana use: evaluation of the correlation between self-report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals. Addiction, 117(1), 172-181. ()
    43. Son SL, Hosek LL, Stein MC, Allshouse AA, Catino AB, Hoskoppal AK, Cox DA, Whitehead KJ, Lindsay IM, Esplin S, Metz TD (2021). Association between pregnancy and long-term cardiac outcomes in individuals with congenital heart disease. Am J Obstet Gynecol, 226(1), 124.e1-124.e8. ()
    44. Smid MC, Metz TD, McMillin GA, Mele L, Casey BM, Reddy UM, Wapner RJ, Thorp JM, Saade GR, Tita ATN, Miller ES, Rouse DJ, Sibai B, Costantine MM, Mercer BM, Caritis SN, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes. Obstet Gynecol, 139(1), 21-30. ()
    45. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson BD (2021). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. Am J Perinatol, 39(6), 567-576. ()
    46. Grobman WA, Sandoval G, Rice MM, Bailit JL, Chauhan SP, Costantine MM, Gyamfi-Bannerman C, Metz TD, Parry S, Rouse DJ, Saade GR, Simhan HN, Thorp JM Jr, Tita ATN, Longo M, Landon MB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network (2021). Prediction of vaginal birth after cesarean delivery in term gestations: a calculator without race and ethnicity. Am J Obstet Gynecol, 225(6), 664.e1-664.e7. ()
    47. Roberts DJ, Edlow AG, Romero RJ, Coyne CB, Ting DT, Hornick JL, Zaki SR, Das Adhikari U, Serghides L, Gaw SL, Metz TD, National Institutes of HealthEunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 Placental Infection Workshop (2021). A standardized definition of placental infection by SARS-CoV-2, a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 Placental Infection Workshop. Am J Obstet Gynecol, 225(6), 593.e1-593.e9. ()
    48. Gilner J, Kansal N, Biggio JR, Delaney S, Grotegut CA, Hardy E, Hirshberg A, Kachikis A, LaCourse SM, Martin J, Metz TD, Miller ES, Norton ME, Sinkey R, Sobhani NC, Son SL, Srinivas S, Tita A, Werner EF, Hughes BL (2021). Universal SARS-CoV-2 testing for obstetric inpatient units across the United States. Clin Infect Dis. ()
    49. Bruno AM, Olmsted MW, Martin V, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue NR (2021). Rigor, reproducibility, and transparency of randomized controlled trials in obstetrics and gynecology. Am J Obstet Gynecol MFM, 3(6), 100450. ()
    50. Bruno AM, Shea AE, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue NR (2021). Impact of the p-Value Threshold on Interpretation of Trial Outcomes in Obstetrics and Gynecology. Am J Perinatol, 38(12), 1223-1230. ()
    51. Bruno AM, Blue NR, Allshouse AA, Haas DM, Shanks AL, Grobman WA, Simhan H, Reddy UM, Silver RM, Metz TD (2021). Marijuana use, fetal growth, and uterine artery Dopplers. J Matern Fetal Neonatal Med, 35, 1-8. ()
    52. Son SL, Allshouse AA, Heinrichs GA, Garite TJ, Silver RM, Wapner RJ, Grobman WA, Chung JH, Mercer BM, Metz TD (2021). Is Exposure to Intrapartum Prostaglandins for Labor Induction Associated with a Lower Incidence of Neonatal Respiratory Distress Syndrome? Am J Perinatol, 38(10), 993-998. ()
    53. Rhoades JS, Ramsey PS, Metz TD, Lewkowitz AK (2021). Maternal-fetal medicine program director experience of exclusive virtual interviewing during the coronavirus disease 2019 pandemic. Am J Obstet Gynecol MFM, 3(4), 100344. ()
    54. Wymore EM, Palmer C, Wang GS, Metz TD, Bourne DWA, Sempio C, Bunik M (2021). Persistence of Δ-9-Tetrahydrocannabinol in Human Breast Milk. JAMA Pediatr, 175(6), 632-634. ()
    55. Lewkowitz AK, Ramsey PS, Burrell D, Metz TD, Rhoades JS (2021). Effect of virtual interviewing on applicant approach to and perspective of the Maternal-Fetal Medicine Subspecialty Fellowship Match. Am J Obstet Gynecol MFM, 3(3), 100326. ()
    56. Mumford SL, Flannagan KS, Radoc JG, Sjaarda LA, Zolton JR, Metz TD, Plowden TC, Perkins NJ, DeVilbiss EA, Andriessen VC, A C PS, Kim K, Yisahak SF, Freeman JR, Alkhalaf Z, Silver RM, Schisterman EF (2019). Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss. Hum Reprod, 36(5), 1405-1415. ()
    57. Metz TD, Clifton RG, Hughes BL, Sandoval G, Saade GR, Grobman WA, Manuck TA, Miodovnik M, Sowles A, Clark K, Gyamfi-Bannerman C, Mendez-Figueroa H, Sehdev HM, Rouse DJ, Tita ATN, Bailit J, Costantine MM, Simhan HN, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol, 137(4), 571-580. ()
    58. Metz TD (2020). Coronavirus disease 2019 pandemic practice changes: more harm than good? BJOG, 128(5), 921. ()
    59. Vastis V, Vincent S, Metz TD, Shea AK (2020). Are Canadian Cannabis Dispensaries Counselling Pregnant Women Appropriately? J Obstet Gynaecol Can, 43(4), 506-510.e2. ()
    60. Lee RHMara Greenberg Metz TDPettker CM (2021). Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011. Am J Obstet Gynecol, 224(2), B2-B9. ()
    61. Swamy GKMetz TDEdwards KMSoper DEBeigi RHCampbell JDGrassano LBuffi GDreisbach AMargarit IKarsten AHenry OLattanzi MBebia Z (2020). Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial. Vaccine, 38(44), 6930-6940. ()
    62. Smid MC, Maeda J, Stone NM, Sylvester H, Baksh L, Debbink MP, Varner MW, Metz TD (2020). Standardized Criteria for Review of Perinatal Suicides and Accidental Drug-Related Deaths. Obstet Gynecol, 136(4), 645-653. ()
    63. Metz TD, Allshouse AA, Pinar H, Varner M, Smid MC, Hogue C, Dudley DJ, Bukowski R, Saade GR, Goldenberg RL, Reddy U, Silver RM (2020). Maternal Marijuana Exposure, Feto-Placental Weight Ratio, and Placental Histology. Am J Perinatol. ()
    64. Society for Maternal-Fetal Medicine SMFM Electronic address pubssmfmorg, Pacheco LD, Saade G, Metz TD (2020). Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery. Am J Obstet Gynecol, 223(2), B11-B17. ()
    65. Pacheco LDSaade GMetz TD (2020). Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery. Am J Obstet Gynecol, 223(2), B11-B17. ()
    66. Madhi SA, Polack FP, Piedra PA, et al and the Prepare Study Group, Metz TD, acknowledgement (2020). Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med, 383(5), 426-439.
    67. Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2020). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstet Gynecol, 136(1), 19-25. ()
    68. American College of Obstetricians and Gyynecologists, Society for Maternal-Fetal Medicine in collaboration with, Metz TD, Berry RS, Fretts RC, Reddy UM Turrentine MA (2020). Obstetric Care Consensus #10: Management of Stillbirth: (Replaces Practice Bulletin Number 102, March 2009). Am J Obstet Gynecol, 22(3), B2B20.
    69. Goodwin RD, Zhu J, Heisler Z, Metz TD, Wyka K, Wu M, Das Eiden R (2020). Cannabis use during pregnancy in the United States: The role of depression. Drug Alcohol Depend, 210, 107881. ()
    70. Gnofam M, Allshouse AA, Stickrath EH, Metz TD (2019). Impact of Marijuana Legalization on Prevalence of Maternal Marijuana Use and Perinatal Outcomes. Am J Perinatol, 37(1), 59-65. ()
    71. Rodriguez CE, Sheeder J, Allshouse AA, Scott S, Wymore E, Hopfer C, Hermesch A, Metz TD (2019). Marijuana use in young mothers and adverse pregnancy outcomes: a retrospective cohort study. BJOG, 126(12), 1491-1497. ()
    72. Goyal N, Herrick JS, Son S, Metz TD, Shah RU (2019). Maternal Cardiovascular Complications at the Time of Delivery and Subsequent Re-Hospitalization in the United States, 2010 to 2016. Eur Heart J Qual Care Clin Outcomes, 7, 304-311. ()
    73. Rodriguez CE, Metz TD, Patel S, Abbaszadeh M, Yoder BA, Bardsley T, Clark EAS (2019). Neonatal Outcomes Associated with Umbilical Cord Milking in Preterm Multiple Gestations. Am J Perinatol, 36(10), 990-996. ()
    74. Metz TD, Stickrath EH (2019). Is Increasing Frequency of Marijuana Use Among Women of Reproductive Age a Cause for Alarm? JAMA Netw Open, 2(7), e196464. ()
    75. Metz T (2019). Pregnancy with Loeys–Dietz: care informed by case series. Am J Obstet Gynecol, 126(8), 1032. ()
    76. Hyer J, Ulrickson C, Yerelian E, Metz TD, Allshouse AA, Hoffman MC (2019). Self-Reported Alcohol, Tobacco, and Marijuana Use in Pregnant Women with Depressive Symptomatology. Am J Perinatol, 37, 1223-1227. ()
    77. Dickson B, Metz TD (2019). In Reply. . Obstet Gynecol, 133(5), 1057.
    78. Plante L and Metz TD (2019). American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics. . Obstet Gynecol, 133(5), 303-19.
    79. Metz TD (2019). Mini Commentary: Pregnancy with Loeys Dietz: Care Informed by Case Series. . BJOG, 126(8), 949-1079.
    80. MetzTD and Prasad M (2019). Intro: Opioids in Pregnancy. Semin Perinatol, 43(3), 121-22.
    81. Smid MC, Metz TD, Gordon AJ (2019). Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women. Clin Obstet Gynecol, 62(1), 168-184. ()
    82. Prasad MR, Metz TD (2019). Foreword: Substance Abuse in Pregnancy. Clin Obstet Gynecol, 62(1), 110-111. ()
    83. Metz TD, McKinney J, Allshouse AA, Knierim SD, Carey JC, Heyborne KD (2019). Exposure to group B Streptococcal antibiotic prophylaxis and early childhood body mass index in a vaginal birth cohort. J Matern Fetal Neonatal Med, 33, 1-6. ()
    84. Metz TD, Silver RM, McMillin GA, Allshouse AA, Jensen TL, Mansfield C, Heard K, Kinney GL, Wymore E, Binswanger IA (2018). Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization. Obstet Gynecol, 133(1), 98-104. ()
    85. Metz TD (2018). What Is New in Maternal Heart Disease?: Best Articles From the Past Year. Obstet Gynecol, 133(1), 181-182. ()
    86. Silver RM, Metz TD (2018). A Simple Step to Reduce Maternal Death: Improve VTE Prevention.
    87. Metz TD, Borgelt LM (2018). Marijuana Use in Pregnancy and While Breastfeeding. Obstet Gynecol, 132(5), 1198-1210. ()
    88. American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics with the assistance of Metz TD and Silverman NS (2018). Inherited Thrombophilias in Pregnancy. 132(4), 1069.
    89. Dickson B and Metz TD (2018). In Reply. Obstet Gynecol, 132(3), 782.
    90. Jarvie JL, Metz TD, Davis MB, Ehrig JC, Kao DP (2018). Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy. Heart, 104(14), 1187-1194. ()
    91. Dickson B, Mansfield C, Guiahi M, Allshouse AA, Borgelt LM, Sheeder J, Silver RM, Metz TD (2018). Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use. Obstet Gynecol, 131(6), 1031-1038. ()
    92. Metz TD (2018). What Is New in Cannabis Use in Pregnancy?: Best Articles From the Past Year. Obstet Gynecol, 131(3), 594-595. ()
    93. Larrea NA, Metz TD (2018). Pregnancy After Uterine Rupture. Obstet Gynecol, 131(1), 135-137. ()
    94. Wu F, Scroggin TL, Metz TD, McMillin GA (2017). Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of Four Cannabinoids in Umbilical Cord Tissue. J Anal Toxicol, 42(1), 42-48. ()
    95. Dotters-Katz SK, Smid MC, Manuck TA, Metz TD (2017). Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana. J Matern Fetal Neonatal Med, 30(24), 2933-2939. ()
    96. Adkins K, Allshouse AA, Metz TD, Heyborne KD (2017). Impact of aspirin on fetal growth in diabetic pregnancies according to White classification. Am J Obstet Gynecol, 217(4), 465.e1-465.e5. ()
    97. Metz TD, Allshouse AA, Hogue CJ, Goldenberg RL, Dudley DJ, Varner MW, Conway DL, Saade GR, Silver RM (2017). Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol, 217(4), 478.e1-478.e8. ()
    98. Robison E, Heyborne K, Allshouse AA, Valdez C, Metz TD (2017). Implementation of a Risk-Based Heparin Protocol for Postpartum Venous Thromboembolism Prevention. Obstet Gynecol, 130(2), 262-269. ()
    99. Metz TD, Gonzalez C, Allshouse AA, Henry E, Esplin S (2017). Influence of Patient-Level Factors on Mode of Delivery among Operative Vaginal Delivery Candidates in Modern Practice. Am J Perinatol, 34(10), 974-981. ()
    100. Alston MJ, Metz TD, Fothergill R, Meg Autry A, Wagner SA, Allshouse AA, Stephenson-Famy A (2017). Factors Influencing Residency Program Selection by Medical Students Pursuing Obstetrics and Gynecology. J Grad Med Educ, 9(1), 123-127. ()
    101. Metz TD, Jackson M, Stoddard G, Yetman AT (2017). Cardiologist Counseling Regarding Pregnancy in Women who Have Undergone an Atrial Switch Procedure for D-Transposition of the Great Arteries. 1(2), 009.
    102. Metz TD, Rovner P, Hoffman MC, Allshouse AA, Beckwith KM, Binswanger IA (2016). Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012. Obstet Gynecol, 128(6), 1233-1240. ()
    103. Andrews SE, Allshouse AA, Moore GS, Alston MJ, Metz TD (2018). Influence of Residency Training on Operative Vaginal Delivery in Independent Practice. J Reprod Med, 61(11-12), 562-8. ()
    104. Faucett AM, Allshouse AA, Donnelly M, Metz TD (2016). Do Obese Women Receive the Necessary Interventions to Achieve Vaginal Birth after Cesarean? Am J Perinatol, 33(10), 991-7. ()
    105. Euser AG, Metz TD, Allshouse AA, Heyborne KD (2016). Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin. J Perinatol, 36(8), 601-5. ()
    106. Tran AH, Best BM, Stek A, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, George K, Cressey TR, Chakhtoura N, Smith E, Shapiro DE, Mirochnick M, Buschur S, Jackson C, Paul M, McGregor D, Yogev R, Kalra R, Florez C, Bryan P, Stone M, Hull AD, Caffery M, Spector SA, Wilson J, Giner J, Donnelly MA, Cooper ER, McLaud DA, Tucker LF, Hitti J, Robson-Nuss A, Melvin AJ, Keller MA, Bolaris MA, Hayes J, Kamer F, Spencer LS, Homans J, Metz T, Wallace J, Katai A, Aziz M, McNichols M, Schmidt J, Wara D, Maka K, Cohan D, Deveikis A, Batra J, Alvarez JJ, Carter M, Deville J, Janzen C, Gutierrez J, Cavallo M, Purswani M, Knapp KM, Sublette N, Wride T (2016). Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women. Am J Obstet Gynecol, 72(3), 289-296. ()
    107. Folsom S, Esplin MS, Edmunds S, Metz TD, Jackson GM, Porter TF, Varner MW (2016). Patient Counseling and Preferences for Elective Repeat Cesarean Delivery. AJP Rep, 6(2), e226-31.
    108. Metz TD, Allshouse AA, Gilbert SAB, Doyle R, Tong A, Carey JC (2016). Variation in primary cesarean delivery rates by individual physician within a single-hospital laborist model. Am J Obstet Gynecol, 214(4), 531.e1-531.e6. ()
    109. Alston MJ, Alexandrovic K, Stiglich N, Metz TD (2016). Discontinuation of Tocolytics for Preterm Labor in an Academic Safety Net Hospital: Impact on the Duration of Betamethasone Exposure. J Reprod Med, 61(3-4), 109-13. ()
    110. Faucett AM, Metz TD, DeWitt PE, Gibbs RS (2016). Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes. Am J Obstet Gynecol, 214(2), 287.e1-287.e5. ()
    111. Metz TD, Stickrath EH (2015). Marijuana in Pregnancy and Lactation: A Review of the Evidence. Am J Obstet Gynecol, 213(6), 761-78.
    112. Mazzoni SE, Bienenfeld SL, Krull MB, Metz TD, Alston MJ (2015). Perinatal High-Grade Cervical Cytology: A Case Series From a Safety Net Institution. J Low Genit Tract Dis, 19(4), 329-32. ()
    113. Andrews SE, Alston MJ, Allshouse AA, Moore GS, Metz TD (2015). Does the number of forceps deliveries performed in residency predict use in practice? Am J Obstet Gynecol, 213(1), 93.e1-93.e4. ()
    114. Metz TD, Allshouse AA, Faucett AM, Grobman WA (2015). Validation of a vaginal birth after cesarean delivery prediction model in women with two prior cesarean deliveries. Obstet Gynecol, 125(4), 948-52. ()
    115. Patel S, Clark EA, Rodriguez CE, Metz TD, Abbaszadeh M, Yoder BA (2014). Effect of umbilical cord milking on morbidity and survival in extremely low gestational age neonates. Am J Obstet Gynecol, 211(5), 519.e1-7. ()
    116. Metz TD, Allshouse AA, Euser AG, Heyborne KD (2014). Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers. Am J Obstet Gynecol, 211(5), 512.e1-6. ()
    117. Fabbri S, Alston M, Metz TD, Krull M (2014). Evaluation of the utility of baseline serum hepatic and renal testing in pregnant patients with chronic hypertension. J Reprod Med, 59(9-10), 471-5. ()
    118. Pinto NM, Nelson R, Puchalski M, Metz TD, Smith KJ (2014). Cost-effectiveness of prenatal screening strategies for congenital heart disease. Ultrasound Obstet Gynecol, 44(1), 50-7. ()
    119. Metz TD, Hayes SA, Garcia CY, Yetman AT (2013). Impact of pregnancy on the cardiac health of women with prior surgeries for pulmonary valve anomalies. Am J Obstet Gynecol, 209(4), 370.e1-6. ()
    120. Metz TD, Stoddard GJ, Henry E, Jackson M, Holmgren C, Esplin S (2013). Simple, validated vaginal birth after cesarean delivery prediction model for use at the time of admission. Obstet Gynecol, 122(3), 571-8. ()
    121. Metz TD, Stoddard GJ, Henry E, Jackson M, Holmgren C, Esplin S (2013). How do good candidates for trial of labor after cesarean (TOLAC) who undergo elective repeat cesarean differ from those who choose TOLAC? Am J Obstet Gynecol, 208(6), 458.e1-6. ()
    122. Lo JO, Boltax J, Metz TD (2013). Cesarean delivery for life-threatening status asthmaticus. Obstet Gynecol, 121(2 Pt 2 Suppl 1), 422-4. ()
    123. Metz TD, Scott JR (2012). Contemporary management of VBAC. Clin Obstet Gynecol, 55(4), 1026-32. ()
    124. Metz TD, Lynch AM, Wolfe P, Barry JS, Galan HL (2012). Effect of small for gestational age on hemodynamic parameters in the neonatal period. J Matern Fetal Neonatal Med, 25(10), 2093-7. ()
    125. Metz TD, Nelson LM, Stoddard GJ, Silver RM (2012). FOXP3 gene polymorphisms in preeclampsia. Am J Obstet Gynecol, 206(2), 165.e1-6. ()
    126. Metz TD, Jackson GM, Yetman AT (2011). Pregnancy outcomes in women who have undergone an atrial switch repair for congenital d-transposition of the great arteries. Am J Obstet Gynecol, 205(3), 273.e1-5. ()
    127. Horne BD, Rasmusson KD, Alharethi R, Budge D, Brunisholz KD, Metz T, Carlquist JF, Connolly JJ, Porter TF, Lappe DL, Muhlestein JB, Silver R, Stehlik J, Park JJ, May HT, Bair TL, Anderson JL, Renlund DG, Kfoury AG (2011). Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovasc Genet, 4(4), 359-66. ()
    128. Metz TD, Abbott JT (2006). Uterine trauma in pregnancy after motor vehicle crashes with airbag deployment: A 30-case series. J Trauma, 61(3), 658-61. ()
    129. Keeley RD, Birchard A, Dickinson P, Steiner J, Dickinson LM, Rymer S, Palmer B, Derback T, Kempe A (2004). Parental attitudes about a pregnancy predict birth weight in a low-income population. Ann Fam Med, 2(2), 145-9. ()
    130. Shafer HO, Derback T, Koval CA (2000). Electron Transfer Reactions of Hydrophobic Metallocenes with Aqueous Redox Couples at Liquid-Liquid Interfaces. 1. Solvent, Electrolyte, Partitioning and Thermodynamic Issues. J Phys Chem B, 104(5), 1025-32.

    Review

    1. Grobman WA, Sandoval GJ, Rice MM, Chauhan SP, Clifton RG, Costantine MM, Gibson KS, Metz TD, Parry S, Reddy UM, Rouse DJ, Saade GR, Simhan HN, Thorp JM Jr, Tita ATN, Yee L, Longo M, Landon MB, of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network (2023). Prediction of vaginal birth after cesarean using information at admission for delivery: a calculator without race or ethnicity. [Review]. Am J Obstet Gynecol, 230(3S), S804-S806. ()
    2. Hudson RE, Metz TD, Ward RM, McKnite AM, Enioutina EY, Sherwin CM, Watt KM, Job KM (2023). Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure. [Review]. Front Pharmacol, 14, 1111601. ()
    3. Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, Baumann S, Adams Waldorf KM, Afshar Y, Ahlberg M, Ahmadzia H, Akelo V, Aldrovandi G, Bevilacqua E, Bracero N, Brandt JS, Broutet N, Carrillo J, Conry J, Cosmi E, Crispi F, Crovetto F, Del Mar Gil M, Delgado-Lpez C, Divakar H, Driscoll AJ, Favre G, Fernandez Buhigas I, Flaherman V, Gale C, Godwin CL, Gottlieb S, Gratacs E, He S, Hernandez O, Jones S, Joshi S, Kalafat E, Khagayi S, Knight M, Kotloff KL, Lanzone A, Laurita Longo V, Le Doare K, Lees C, Litman E, Lokken EM, Madhi SA, Magee LA, Martinez-Portilla RJ, Metz TD, Miller ES, Money D, Moungmaithong S, Mullins E, Nachega JB, Nunes MC, Onyango D, Panchaud A, Poon LC, Raiten D, Regan L, Sahota D, Sakowicz A, Sanin-Blair J, Stephansson O, Temmerman M, Thorson A, Thwin SS, Tippett Barr BA, Tolosa JE, Tug N, Valencia-Prado M, Visentin S, von Dadelszen P, Whitehead C, Wood M, Yang H, Zavala R, Tielsch JM (2022). Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. [Review]. Am J Obstet Gynecol, 228(2), 161-177. ()
    4. Boettcher LB, Metz TD (2023). Maternal and neonatal outcomes following SARS-CoV-2 infection. [Review]. Semin Fetal Neonatal Med, 28(1), 101428. ()
    5. Goulding AN, Metz TD, Middleton JC, Hoffman MC, Miller ES, Moore Simas TA, Stuebe A, Viswanathan M, Gaynes BN (2021). Pharmacologic Treatment for Perinatal Mental Health Disorders. [Review]. Obstet Gynecol, 139(2), 297-303. ()
    6. Townsel C, Metz TD, Bunik M (2021). The Term Newborn: Prenatal Substance Exposure. [Review]. Clin Perinatol, 48(3), 631-646. ()
    7. Society for Maternal-Fetal Medicine SMFM Electronic address pubssmfmorg, Lee RH, Mara Greenberg, Metz TD, Pettker CM (2020). Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011. [Review]. Am J Obstet Gynecol, 224(2), B2-B9. ()
    8. Metz TD, Collier C, Hollier LM (2020). Maternal Mortality From Coronavirus Disease 2019 (COVID-19) in the United States. [Review]. Obstet Gynecol, 136(2), 313-316. ()
    9. Metz T, Prasad M (2019). Introduction. [Review]. Am J Obstet Gynecol, 43(3), 121-122. ()
    10. Metz TD, Silverman NS (2018). ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy. [Review]. Am J Obstet Gynecol, 132(1), E18-E34. ()
    11. Metz TD, Khanna A (2016). Evaluation and Management of Maternal Cardiac Arrhythmias. [Review]. Obstet Gynecol Clin North Am, 43(4), 729-745. ()
    12. Faucett AM, Metz TD (2016). Delivery of the Obese Gravida. [Review]. Clin Obstet Gynecol, 59(1), 180-92. ()
    13. Metz TD, Stickrath EH (2015). Marijuana use in pregnancy and lactation: a review of the evidence. [Review]. Am J Obstet Gynecol, 213(6), 761-78. ()
    14. Metz TD, Dugoff L (2008). Role of Thrombophilia in Early Recurrent Pregnancy Loss. [Review]. 28(22), 1-5.

    Book Chapter

    1. Metz TD, Silver RM (2022). Maternal Mortality. In Creasy and Resnik’s Maternal Fetal-Medicine: Principles and Practice (9th Edition). Elsevier.
    2. Gimbel LA, Metz TD (2021). Uterine inversion. In Operative Techniques in Obstetric Surgery.
    3. Bridges A, Metz TD (2020). Thrombophilias. In Reece’s Clinical Obstetrics: The Fetus and Mother, 4th Edition. Wolters Kluwer.
    4. Metz TD, Silver RM (2020). Maternal Mortality, Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practices (8th edition).
    5. Prasad M and Metz TD (2019). Substance Use Disorder in Pregnancy. Gabbe’s Obstetrics: Normal and Problem Pregnancies.
    6. Little L, Metz TD (2015). Maternal Air Medical Transport. In Blumen IJ, Bolton L, Davidoff JB, Dhindsa HS, MacDonald R, Martin PS, Petersen P (Eds.), Principles and Direction of Air Medical Transport (2nd Edition). Salt Lake City, UT: Air Medical Physician Association.

    Conference Proceedings

    1. Metz TD, Nelson LM, Stoddard GJ, Silver RM (2012). FOXP3 gene polymorphisms in preeclampsia. In Metz TD|Nelson LM|Stoddard GJ|Silver RM (Ed.), Am J Obstet Gynecol, 206(2), 165.e1-165.e6. ()
    2. Metz T, Jackson G, Yetman A (2011). Pregnancy outcomes in women who have undergone an atrial switch repair for congenital d-transposition of the great arteries. In Metz T|Jackson G|Yetman A (Ed.), Am J Obstet Gynecol, 205(3), 273.e1-273.e5. ()

    Case Report

    1. Alaniz VI, Liss J, Metz TD, Stickrath E (2015). Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy. Obstet Gynecol, 125(6), 1484-6. ()
    2. Metz T, Trierweiler M, Arrigo AM, Winn VD (2009). Uterine torsion in delayed diagnosis of abnormal anterior placentation: a report of 2 cases. J Reprod Med, 54(5), 322-4. ()

    Editorial

    1. Joseph NT, Metz TD (2021). Coronavirus Disease 2019 (COVID-19) and Pregnancy Outcomes: State of the Science. Obstet Gynecol, 138(4), 539-541. ()
    2. Metz TD (2020). Is Universal Testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Needed on All Labor and Delivery Units? Obstet Gynecol, 136(2), 227-228. ()
    3. Chung JH, Stone J, Gyamfi-Bannerman C, Metz TD, Society for Maternal-Fetal Medicine Fellowship Affairs Committee (2019). What can we do to make the fellowship application process better? Am J Obstet Gynecol MFM, 1(4), 100054. ()
    4. Metz TD, Gill L, Silver RM, Society for Maternal-Fetal Medicine Fellowship Affairs Committee (2019). Society for Maternal-Fetal Medicine's Fellow Research Series 2018: Manuscripts of the Year. Am J Perinatol, 36(1), 1-2. ()
    5. Metz TD (2018). Eliminating Preventable Maternal Deaths in the United States: Progress Made and Next Steps. Obstet Gynecol, 132(4), 1040-1045. ()

    Letter

    1. Einerson BD, Allshouse AA, Sandoval G, Nelson RE, Esplin MS, Varner M, Grobman WA, Metz TD, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units Network (2024). Source of variation in cost of obstetrical care for low-risk nulliparas at term. [Letter to the editor]. Am J Obstet Gynecol, 230(5), e99-e100. ()
    2. Smid MC, Charron E, Allshouse AA, Campbell K, Metz TD, Debbink MP, Cochran G (2023). Co-occurring opioid and methamphetamine use disorder and severe maternal morbidity and mortality. [Letter to the editor]. Am J Obstet Gynecol MFM, 101221. ()
    3. Metz TD, Allshouse AA, McMillin GA, Silver RM, Smid MC, Haas DM, Simhan HN, Saade GR, Grobman WA, Parry S, Chung JH, Jarlenski MP (2022). Association of Cannabis Use With Nausea and Vomiting of Pregnancy. [Letter to the editor]. Obstet Gynecol, 140(2), 266-270. ()
    4. Bruno AM, Allshouse AA, Einerson BD, Campbell HM, Branch DW, Silver RM, Metz TD (2022). Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients. [Letter to the editor]. Am J Obstet Gynecol MFM, 4(4), 100620. ()
    5. Bruno AM, Allshouse AA, Metz TD, Theilen LH (2022). Trends in Hypertensive Disorders of Pregnancy in the United States From 1989 to 2020. [Letter to the editor]. Obstet Gynecol, 140(1), 83-86. ()
    6. Guiahi M, Mazzoni S, Metz T, Alston M (2019). Impact of a structured obstetrics and gynecology residency research program [Letter to the editor]. Am J Obstet Gynecol, 221(4), 364-365. ()
    7. Dickson B, Metz T (2019). In Reply [Letter to the editor]. Am J Obstet Gynecol, 133(5), 1057. ()
    8. Dickson B, Metz T (2018). In Reply [Letter to the editor]. Am J Obstet Gynecol, 132(3), 782. ()
    9. Lusero I, Paltrow LM, Rosenbloom N, Dickson B, Metz T (2018). Recommendations from Cannabis Dispensaries about First-Trimester Cannabis Use [Letter to the editor]. Am J Obstet Gynecol, 132(3), 781-782. ()

    Abstract

    1. Metz TD, Allshouse AA, McMillin GA, Silver RM, Jarlenski MP (2022). Association of Marijuana Use with Nausea and Vomiting of Pregnancy. Society for Maternal-Fetal Medicine Annual Meeting, February 2022, oral presentation. [Abstract].
    2. Bruno AM, Allshouse AA, Metz TD, Theilen LH (2022). Trends in Hypertensive Disorders of Pregnancy in the U.S. from 1989 to 2018. Society for Maternal-Fetal Medicine Annual Meeting, February 2022. [Abstract].
    3. Debbink MP, Tavake-Pasi OF, Vaitohi S, Flake N, Witte B, Varner MW, Metz TD (2022). Community Risk and Resilience for Perinatal Health among Native Hawaiian and Pacific Islander mothers. Society for Maternal-Fetal Medicine Annual Meeting, February 2022. [Abstract].
    4. Debbink MP, Tavake-Pasi OF, Vaitohi S, Flake N, Witte B, Varner MW, Metz TD (2022). Native Hawaiian and Pacific Islander Mothers’ Experiences with Obstetric Care Providers and Health Systems. Society for Maternal-Fetal Medicine Annual Meeting, February 2022. [Abstract].
    5. Cummins H, Allshouse AA, Metz TD, Debbink MP (2022). Pilot Non-inferiority Study of Group Prenatal Care Versus Standard Care for Pregnant People with Diabetes. Society for Maternal-Fetal Medicine Annual Meeting, February 2022. [Abstract].
    6. Shea A, Debbink MP, Nourse S, Kroes A, Janes S, Heuser C, Varner MW, Metz TD (2021). Characteristics of preventable severe maternal morbidity. Society for Reproductive Investigation Annual Meeting, Boston, MA, July 2021. [Abstract].
    7. Bruno AM, Allshouse AA, Silver RM, Branch DW, Campbell H, Einerson B, Metz TD (2021). Trends in Postpartum Venous Thromboembolism and Chemical Thromboprophylaxis among Insured U.S. Patients. Society for Reproductive Investigation Annual Meeting, Boston, MA, July 2021. [Abstract].
    8. Bruno AM, Benson AE, Metz TD, Blue NR (2021). Adjunct Therapy at Time of Exam-Indicated Cervical Cerclage in Singleton Pregnancies: A Systematic Review and Meta-Analysis. Society for Reproductive Investigation Annual Meeting, Boston, MA, July 2021. [Abstract].
    9. Norton MEKuller JAMetz TD (2021). Society for Maternal-Fetal Medicine Special Statement: Grading of Recommendations Assessment, Development, and Evaluation (GRADE) update [Abstract]. Am J Obstet Gynecol, 224(4), B24-B28. ()
    10. Metz TD for the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Maternal and Neonatal Outcomes of Pregnant Patients with Coronavirus Disease 2019 (COVID-19): A Multistate Cohort. Society for Maternal-Fetal Medicine Annual Meeting, virtual meeting, late-breaking plenary presentation, January 28, 2021. [Abstract].
    11. Smid M, McMillin GA, Metz TD for the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Early prenatal marijuana and nicotine exposure and child neurodevelopmental outcomes. Society for Maternal-Fetal Medicine Annual Meeting, virtual meeting, oral presentation, January 28, 2021. [Abstract].
    12. Bruno AM, Martin V, Olmsted MW, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue NR (2021). Transparency in OB-GYN trial reporting: Are we deficient? Society for Maternal-Fetal Medicine Annual Meeting, virtual meeting, January 28, 2021. [Abstract].
    13. Bruno AM, Olmsted MW, Martin V, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue NR (2021). Pre-trial registration as accountability in manuscript publication. Society for Maternal-Fetal Medicine Annual Meeting, virtual meeting, January 28, 2021. [Abstract].
    14. Smid M, Allshouse AA, Campbell K, Debbink MP, Gordon AG, Kim J, Metz TD, Varner MW, Waitzman N, West N, Cochran J (2021). Co-occurring opioid and methamphetamine use disorder and severe maternal morbidity and mortality in Utah. Society for Maternal-Fetal Medicine Annual Meeting, virtual meeting, January 28, 2021. [Abstract].
    15. Merriam AA, Metz TD, Allshouse AA, Silver RM, Haas DM, Grobman WA, Wapner RJ, Wing D, Reddy UM (2021). Markers of maternal morbidity in nulliparous women. Society for Maternal-Fetal Medicine Annual Meeting, virtual meeting, January 28, 2021. [Abstract].
    16. Metz TD, Binswanger IA, McMillin GA, Allshouse AA, Heard K, Jensen TL, Wymore E, Stickrath EH, Conageski C, Kinney GL, Silver RM (2020). Measurement of Prenatal Marijuana Use with Bioassays and Survey Data, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX, February 8, 2020. [Abstract].
    17. Bruno AM, Shea AE, Allshouse AA, Einerson BD, Metz TD, Scott JR, Blue NR (2020). Does Lowering the P-Value Threshold Render RCTs Insignificant in Leading Ob/Gyn Journals? Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX, February 8, 2020. [Abstract].
    18. Son SL, Hosek LL, Stein MC, Allshouse AA, Catino AB, Hoskoppal AK, Cox DA, Whitehead KJ, Lindsay IM, Esplin S, Metz TD (2020). Does Pregnancy Impact Subsequent Cardiac Outcomes of Women with Congenital Heart Disease? Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX, February 7, 2020. [Abstract].
    19. Metz TD, Blue NR, Allshouse AA, Grobman WA, Simhan H, Reddy U, Mercer BM, Silver RM (2020). Marijuana Use, Fetal Growth and Uterine Artery Dopplers, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX, February 6, 2020. [Abstract].
    20. Vastis V, Shea AK, Vincent S, Metz TD (2020). Are Canadian Cannabis Dispensaries Counseling Women Appropriately? Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX, February 6, 2020. [Abstract].
    21. Son SL, Allshouse AA, Heinrichs GA, Garite TJ, Silver RM, Wapner RJ, Grobman WA, Chung JH, Mercer BM, Metz TD (2020). Association Between Intrapartum Prostaglandin Exposure and Neonatal Respiratory Distress Syndrome, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX, February 6, 2020. [Abstract].
    22. Gnofam M, Allshouse AA, Metz TD (2019). Impact of Legalization of Prevalence of Maternal Marijuana Use and Obstetrical Outcomes, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV, February 15, 2019. [Abstract].
    23. Smid M, Maeda J, Stone N, Baksh L, Einerson BD, Gordon AJ, Powers FJ, Varner MW, Clark EAS, Metz TD (2019). Drug-Related Maternal Deaths in Utah, 2013-16, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV, February 14, 2019. [Abstract].
    24. Metz TD, Binswanger IA, McMillin GA, Allshouse AA, Heard K, Jensen TL, Wymore E, Stickrath EH, Conageski C, Kinney GL, Silver RM (2019). Measurement of Prenatal Marijuana Use with Bioassays and Survey Data, accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX. [Abstract].
    25. Bruno AM, Shea AE, Allshouse AA, Einerson BD, Metz TD, Scott JR, Blue NR (2019). Does Lowering the P-Value Threshold Render RCTs Insignificant in Leading Ob/Gyn Journals?  accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX. [Abstract].
    26. Son SL, Hosek LL, Stein MC, Allshouse AA, Catino AB, Hoskoppal AK, Cox DA, Whitehead KJ, Lindsay IM, Esplin S, Metz TD (2019). Does Pregnancy Impact Subsequent Cardiac Outcomes of Women with Congenital Heart Disease? accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX. [Abstract].
    27. Metz TD, Blue NR, Allshouse AA, Grobman WA, Simhan H, Reddy U, Mercer BM, Silver RM (2019). Marijuana Use, Fetal Growth and Uterine Artery Dopplers, accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX. [Abstract].
    28. Vastis V, Shea AK, Vincent S, Metz TD (2019). Are Canadian Cannabis Dispensaries Counseling Women Appropriately? accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX. [Abstract].
    29. Son SL, Allshouse AA, Heinrichs GA, Garite TJ, Silver RM, Wapner RJ, Grobman WA, Chung JH, Mercer BM, Metz TD (2019). Association Between Intrapartum Prostaglandin Exposure and Neonatal Respiratory Distress Syndrome, accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting, Grapevine, TX. [Abstract].
    30. Wymore E, Palmer C, Wang G, Metz TD, Bourne D, Henthorne T, Sempio C, Klawitter J, Bunik M (2018). Excretion and Persistence of Marijuana in Human Breastmilk, accepted for podium presentation, Pediatric Academic Society Annual Meeting, Toronto, Canada. [Abstract].
    31. Mazzoni S, Alston M, Metz TD, Guiahi M (2018). Impact of a Structured Resident Research Program on Scholarly Productivity, accepted for presentation, CREOG and APGO Annual Meeting, National Harbor, MD. [Abstract].
    32. Gnofam M, Allshouse AA, Metz TD (2018). Impact of Legalization of Prevalence of Maternal Marijuana Use and Obstetrical Outcomes, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV. [Abstract].
    33. Smid M, Maeda J, Stone N, Baksh L, Einerson BD, Gordon AJ, Powers FJ, Varner MW, Clark EAS, Metz TD (2018). Drug-Related Maternal Deaths in Utah, 2013-16, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV. [Abstract].
    34. Dickson B, Mansfield C, Guiahi M, Allshouse AA, Borgelt L, Sheeder J, Silver RM, Metz TD (2018). Recommendations from Cannabis Dispensaries on First Trimester Marijuana Use, accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting. [Abstract].
    35. Metz TD, Silver RM, McMillin GA, Allshouse AA, Mansfield C, Heard K, Kinney GL, Wymore E, Binswanger IA (2018). Maternal Marijuana Exposure by Self-Report and Umbilical Cord Sampling in a State with Legalization, accepted for presentation, Society for Maternal-Fetal Medicine Annual Meeting. [Abstract].
    36. Rodriguez CE, Sheeder J, Allshouse AA, Hermesch A, Metz TD (2018). Marijuana Use and Adverse Perinatal Outcomes in Young Mothers, accepted for fellow’s oral plenary presentation, Society for Maternal-Fetal Medicine Annual Meeting, Awarded Best Fellow Plenary presentation of the meeting. [Abstract].
    37. Scroggin T, Wu F, Metz TD, Allshouse AA, Binswanger I, McMillin GA (2018). Detection of In Utero Exposure to Cannabis, What are We Missing?, accepted for presentation, Mass Spectrometry: Applications to the Clinical Lab Annual Meeting U.S., Palm Springs, CA. [Abstract].
    38. Scroggin T, Wu F, Metz TD, Allshouse AA, Binswanger I, McMillin GA (2018). Detection of In Utero Exposure to Cannabis, What are We Missing?, accepted for presentation, Mass Spectrometry: Applications to the Clinical Lab Annual Meeting U.S., Palm Springs, CA,  [Abstract].
    39. Hyer J, Yerelian E, Metz TD, Allshouse AA, Hoffman C (2017). Self-Reported Alcohol and Substance Use in Women with Depressive Symptoms, 3rd Biennial Perinatal Mental Health Conference, Chicago, IL. [Abstract].
    40. Allshouse AA, Metz TD, Heyborne KD (2017). Racial Disparities in Group B Streptococcal (GBS) Colonization, accepted for oral presentation, American Public Health Association, Atlanta, GA. [Abstract].
    41. Wright R, Trierweiler K, Heaberlin T, McMahon M, Bohling Smith P, Metz TD (2017). Implementation of the Levels of Care Assessment Tool e-Version (LOCATe) in Colorado, accepted for podium presentation, Vermont Oxford Network Annual Quality Congress, Chicago, IL. [Abstract].
    42. McKinney J, Metz, TD, Allshouse AA, Knierim S, Carey JC, Heyborne KD (2017). Is Group B Streptococcus Intrapartum Antibiotic Prophylaxis Associated with Increased Early Childhood BMI?, Infectious Diseases Society for Obstetrics and Gynecology, Park City, UT. [Abstract].
    43. Metz TD, Allshouse AA, Hermesch A, Alston M, Gilbert SB, Saade G (2017). Apgar Score and Umbilical Cord Gas as Quality Markers for Identification of Unindicated Cesareans, American College of Obstetricians and Gynecologists Annual Meeting, San Diego, CA. [Abstract].
    44. Larrea N, Allshouse AA, Dix B, Metz TD (2017). Influence of Provider Counseling on Decision to Pursue Trial of Labor after Cesarean (TOLAC) among Latina Women, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV. [Abstract].
    45. Metz TD (2017). NICHD Stillbirth Collaborative Research Network. Maternal Marijuana Use and Adverse Perinatal Outcomes among Live Births, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV. [Abstract].
    46. Robison E, Heyborne KD, Allshouse AA, Valdez C, Metz TD (2017). Implementation of a Risk-Based Low Molecular Weight Heparin Protocol for Venous Thromboembolism Prevention in Postpartum Women, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV. [Abstract].
    47. Adkins K, Allshouse AA, Metz TD, Heyborne KD (2017). Impact of Low-Dose Aspirin on Fetal Growth in Diabetic Pregnancies: the Importance of White Classification, Society for Maternal-Fetal Medicine Annual Meeting, Las Vegas, NV. [Abstract].
    48. Metz TD, Silver RM, Allshouse AA, Binswanger IA (2016). Longitudinal Assessment of Maternal Marijuana Exposure, Women’s Reproductive Health Research Scholar Retreat, Augusta, GA.  [Abstract].
    49. Hulings J, Carten M, Pappas J, Alexander S, Trout S, Davies J, Kinzie K, Metz TD, Dinnebiel M, McFarland E, Weinberg A (2016). Outcomes and Future Directions of the HOPE Program: A Comprehensive Reproductive Care Program for Persons Living with HIV, American Conference for the Treatment of HIV, Dallas, TX. [Abstract].
    50. Rodriguez CE, Metz TD, Sheeder J (2016). Marijuana Use in Pregnant Teens Before and After Legalization, Society for Reproductive Investigation, Montreal, Canada. [Abstract].
    51. Allshouse AA, Metz TD (2016). Trends in Self-Reported and Urine-Toxicology Detected Maternal Marijuana Use Before and After Legalization, Society for Maternal-Fetal Medicine Annual Meeting, Atlanta, GA. [Abstract].
    52. Metz TD, Allshouse AA, Babcock S, Doyle R, Tong A, Carey JC (2016). Variation in Primary Cesarean Delivery Rates by Individual Physician within a Single Hospital Laborist Model, Oral presentation, Society for Maternal-Fetal Medicine Annual Meeting, Atlanta, GA. [Abstract].
    53. Metz TD, Rovner P, Allshouse AA, Beckwith K, Hoffman MC, Binswanger I (2016). Maternal Deaths from Suicide and Drug Overdose in Colorado, Society for Maternal-Fetal Medicine Annual Meeting, Atlanta, GA. [Abstract].
    54. Clark EAS, Patel S, Rodriguez CE, Metz TD, Yoder BA (2015). Umbilical Cord Milking in Extremely Low Gestational Age Males Versus Females, Society for Reproductive Investigation Annual Meeting, San Francisco, CA. [Abstract].
    55. Gilbert SB, Allshouse AA, Doyle R, Stickrath E, Heyborne K, Metz TD (2015). Indication for Primary Cesarean Delivery at an Institution with a Low Cesarean Rate Compared with the Consortium on Safe Labor Cohort, Society for Reproductive Investigation Annual Meeting, San Francisco, CA. [Abstract].
    56. Euser AG, Metz TD, Allshouse AA, Heyborne K (2015). Low-dose Aspirin Reduces the Incidence of Preeclampsia in Women with Multiple Gestations and Elevated Human Chorionic Gonadotropin,Oral presentation, Society for Reproductive Investigation Annual Meeting, San Francisco, CA. Awarded Pfizer-SRI President’s Presenter’s Award as one of 25 best abstracts at the meeting from individuals still in training. [Abstract].
    57. Rodriguez CE, Patel S, Metz TD, Abbaszadeh M, Yoder BA, Clark EAS (2015). Effect of Umbilical Cord Milking on Morbidity and Survival in Preterm Neonates from Multiple Gestations, Society for Maternal-Fetal Medicine Annual Meeting, San Diego, CA. [Abstract].
    58. Faucett AM, Donnelly M, Allshouse AA, Metz TD (2015). Do Obese Women Get a Fair Attempt at Vaginal Birth After Cesarean?, Society for Maternal-Fetal Medicine Annual Meeting, San Diego, CA. [Abstract].
    59. Faucett AM, Metz TD, Dewitt PE, Gibbs RS (2015). Effect of Pre-Pregnancy Obesity of Neonatal Outcomes in Pregnancies Complicated by PPROM, Society for Maternal-Fetal Medicine Annual Meeting, San Diego, CA. [Abstract].
    60. Edmunds S, Folsom S, Metz TD, Esplin MS (2015). Patient Counseling and Preferences for Elective Repeat Cesarean Delivery, Society for Maternal-Fetal Medicine Annual Meeting, San Diego, CA. [Abstract].
    61. Metz TD, Allshouse AA, Grobman W (2015). Validation of Vaginal Birth After Cesarean Prediction Model in Women with Two Prior Cesarean Deliveries, Society for Maternal-Fetal Medicine Annual Meeting, San Diego, CA. [Abstract].
    62. Metz TD, Allshouse AA, Henry E, Esplin S, Andrews S, Garite TJ (2014). Choice of Cesarean in Operative Vaginal Delivery Candidates Based on Physician Instrument Preference, Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Chicago, IL. [Abstract].
    63. Gonzales C, Allshouse AA, Henry E, Esplin S, Metz TD (2014). Factors Influencing Delivery Mode in Candidates for Operative Vaginal Delivery in Modern Practice, Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Chicago, IL. [Abstract].
    64. Bienenfeld S, Krull M, Mazzoni S, Metz TD, Alston M (2014). Adherence with Postpartum Follow-up in Patients with High Grade Pap Smears During Pregnancy, American Society for Colposcopy and Cervical Pathology Biennial Scientific Meeting, Scottsdale, AZ. [Abstract].
    65. Andrews S, Allshouse AA, Moore G, Alston M, Metz TD (2014). Association of Residency Training Experience with Instrument Choice for Operative Vaginal Delivery in Practice, Society for Gynecologic Investigation, Florence, Italy. [Abstract].
    66. Andrews S, Allshouse AA, Moore G, Alston M, Metz TD (2014). Does the Number of Forceps Deliveries Performed in Residency Predict Use in Independent Practice?, Oral presentation at the Council for Resident Education in Obstetrics and Gynecology (CREOG) and Association of Professors of Gynecology and Obstetrics (APGO) Annual Meeting, Atlanta, GA. Awarded 3rd place for best oral presentation of the meeting. [Abstract].
    67. Patel S, Metz TD, Rodriguez CE, Abbaszadeh MT, Clark EAS, Yoder B (2013). Cord Milking Improves Survival and Hemodynamic Stability in Immature Infants, American Academy of Pediatrics National Conference and Exhibition, Orlando, FL. [Abstract].
    68. Metz T, Hayes SA, Garcia CY, Yetman AT (2013). Impact of Multiparity on Peripartum and Cardiovascular Outcomes in Women with Repaired Tetralogy of Fallot, Oral presentation at the Annual Meeting of the Society for Maternal-Fetal Medicine, San Francisco, CA. [Abstract].
    69. Pinto NM, Nelson R, Puchalski M, Metz TD, Smith K (2012). Cost Effectiveness of Prenatal Screening Strategies for Congenital Heart Disease, American Society of Echocardiography Scientific Sessions, National Harbor, MD. [Abstract].
    70. Metz TD, Stoddard G, Henry E (2012). A Simple VBAC Prediction Model for Use at the Time of Admission, Annual Meeting for the Society of Gynecologic Investigation, San Diego, CA. [Abstract].
    71. Metz TD, Stoddard GJ, Henry E (2012). How Do Good Candidates for TOLAC Who Choose Elective Repeat Cesarean Differ from Those Who Choose TOLAC?, Annual Meeting for the Society of Gynecologic Investigation, San Diego, CA.  [Abstract].
    72. Metz TD, Jackson MJ, Yetman AT (2012). Pregnancy in Women with Repaired Coarctation and Bicuspid Aortic Valve, Annual Meeting for the Society of Gynecologic Investigation, San Diego, CA. [Abstract].
    73. Metz TD, Henry E, Stoddard GJ, Yoder B, Milan K, Esplin MS (2011). Cesarean Is Associated With Increased Respiratory Morbidity in Preterm Neonates, Woman and Child Institute Annual Meeting, Salt Lake City, UT. [Abstract].
    74. Metz TD, Jackson GM, Yetman A (2011). Pregnancy and Maternal Outcomes in Women Who Have Undergone Repair of Congenital d-Transposition of the Great Arteries, Woman and Child Institute Annual Meeting, Salt Lake City, UT. [Abstract].
    75. Metz TD, Jackson GM, Yetman A (2011). Physician Counseling Regarding Pregnancy in Women Who Have Undergone an Atrial Switch Procedure for d-Transposition of the Great Arteries, Annual Meeting of the Pediatric Academic Society, Denver, CO. [Abstract].
    76. Metz TD, Jackson GM, Yetman A (2011). Pregnancy and Maternal Outcomes in Women Who Have Undergone Repair of Congenital d-Transposition of the Great Arteries, Annual Meeting of the Society for Maternal-Fetal Medicine, San Francisco, CA. [Abstract].
    77. Metz TD, Henry E, Stoddard GJ, Yoder B, Milan K, Esplin MS (2011). Cesarean Is Associated With Increased Respiratory Morbidity in Preterm Neonates, Annual Meeting of the Society for Maternal-Fetal Medicine, San Francisco, CA. [Abstract].
    78. Metz TD, Lynch A, Wolfe P, Barry J and Galan H (2010). The Effect of Small for Gestational Age on Hemodynamic Parameters in the Neonatal Period: A Case-Control Study, Annual Meeting for the Society of Gynecologic Investigation, Orlando, FL.   [Abstract].
    79. Metz TD, Nelson L, Milan K, Silver RM (2010). FOXP3 Gene Polymorphisms in Preeclampsia, Annual Meeting for the Society of Gynecologic Investigation, Orlando, FL.  [Abstract].
    80. Metz TD, Manuck TA, Holmgren C, Henry E, Milan K and Porter TF (2010). Category II Fetal Heart Rate Tracings Are Associated With Increased Risk of Operative Delivery, Annual Meeting of the Society for Maternal-Fetal Medicine, Chicago, Illinois. [Abstract].
    81. Metz TD, Lynch A, Wolfe P, Barry J and Galan H (2008). The Effect of Intrauterine Growth Restriction On Hemodynamic Parameters in the Neonatal Period: A Case-Control Study, Resident Research Day, UCDHSC, Aurora, Colorado. [Abstract].
    82. Metz TD and Abbott JT (2004). Uterine Trauma Following Motor Vehicle Crashes With Air Bag Deployment: A 30-case Series, Annual Meeting of the Society of Academic Emergency Medicine,  Orlando, Florida. [Abstract].
    83. Derback Metz T, Keeley R, Smith A (2000). An Investigation of How Pregnancy Intention Changes from Early Pregnancy to Postpartum, North American Primary Care Research Group, 28th Annual Meeting, Amelia Island, Florida.  [Abstract].
    84. Derback Metz T, Keeley R, Smith (2000). An Investigation of How Pregnancy Intention Changes from Early Pregnancy to Postpartum, Annual Student Research Forum, Ï㽶ÊÓƵ of Colorado Health Sciences Center. [Abstract].

    Other

    1. Metz TD (2020). Choosing the Route of Delivery After Cesarean Birth.
    2. Metz TD (2020). Trial of Labor after Cesarean Delivery: Intrapartum Management.
    3. Metz TD (2014). Methods for Predicting Successful Trial of Labor after Cesarean Delivery. UpToDate. Waltham, MA.
  • Clinical Trials